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A B S T R A C T
Background: Propolis is a resinous material extracted from bee glue with a complex chemical composition. The
unique biological properties of propolis have led to its use in alternative medicine and as a nutritional sup-
plement. Recent research shows that propolis could affect the immune system by decreasing the production of
inflammatory cytokines and potentiating an effect on resident stem cells. The exact mechanism, however, is
unknown. The goal of this study was to demonstrate whether green propolis extract affects any characteristic
properties of mesenchymal stromal cells (MSCs)in vitro.
Methods: The cytocompatibility of propolis extract and the proliferation of bone marrow mesenchymal stromal
cells (BMMSCs) in the presence of propolis was evaluated by live/dead cell staining and MTS viability assay over
a period of 3 days. Also, we evaluated the effect of propolis extract on trilineage differentiation and migration
capacity of undifferentiated and differentiated BMMSCs.
Results: Relative to the control, propolis extract resulted in a significant and linear increase in the proliferation
of MSCs and inhibited the osteogenic differentiation of BMMSCs, while there was a potentiation of chon-
drogenesis and adipogenesis. Finally, in relevance to wound healing, an in vitro scratch assay demonstrated that
the migratory potential of differentiated BMMSCs was enhanced in the presence of propolis.
Conclusion: We have demonstrated that propolis extract was not toxic to BMMSCs (< 400 μg/ml), supported
their proliferation, potentiated chondrogenic and adipogenic differentiation processes, and supported cell mi-
grationin vitro. Most interestingly, there was a down-regulation of osteogenesis. These data support the use of
propolis extract for enhanced cell proliferation and tissue regeneration; however, it warrants further in-
vestigation.
1. Introduction
Natural extracts represent a promising source of alternative medi-
cine for many degenerative diseases. Their effect is mediated by dif-
ferent factors, including their capacity to recruit stem cells, to increase
their proliferation, to migrate, and to enhance the differentiation of
endogenous stem cells [1–3]. Propolis is classified as a natural extract
from honeybee glue. It has been proven to have several positive bio-
logical effects, such as being anti-inflammatory, anti-ulcerative, anti-
bacterial, anti-oxidant, anti-tumor, and immunomodulatory, which fa-
vors its use in alternative medicine [4–13].
Propolis extracts exhibit complex chemical compositions and have
been reported to contain more than 300 organic and inorganic
compounds [14,15]. The major chemical components of Brazilian green
propolis extracts are prenylated phenylpropanoids, including caffeic
acids, cinnamic acids, P-coumoric acid, ferulic acid, and their deriva-
tives. Caffeic acid phenethyl ester (CAPE) is one of the active compo-
nents of propolis, which has been purified and tested in vitro and in vivo.
CAPE has been shown to be effective for bone and cartilage regenera-
tion [16–18], and some research has shown it to have an anticancer
effect [19,20]. Studies have also demonstrated that ferulic acid has a
significant effect on nerve regeneration [21,22] and neovascularization
[23]. Cinnamic acid and its derivatives have been shown to protect
against diabetes [24]. Recently, 9 compounds in the brazilian green
propolis were found to possess free radical scavengers. Caffeoylquinic
acids and artepillin C exhibited strong antioxidant activity [25]. All of
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these components render propolis extracts with a unique bioactive ef-
fect. Due to the significant variation in composition, the exact biolo-
gical function of propolis in vivo is still under investigation.
In vitro, propolis extract has been evaluated for its cytotoxicity and
regenerative capacity using stem cells derived from dental pulp, ex-
foliated deciduous teeth [26–28], odontoblast, osteoclasts [29,30], and
fibroblasts derived from skin and periodontal ligament [31–33]. Cyto-
toxicity of propolis has also been tested on macrophages [34–36]. In
another study, CAPE was shown to enhance the proliferative capacity of
umbilical cord blood-derived hematopoietic stem cells in vitro [37].
In addition, propolis has been found to have a protective effect
against apoptosis, as it decreased the apoptosis of periodontal ligament
fibroblasts (PLF) without any cytotoxicity. These data suggested that
propolis could serve as a beneficial storage medium for an avulsed
tooth, as it could increase the viability and the physiological capability
of PLF [38].
At the site of injury, macrophages are responsible for the induction
of inflammation through the production of inflammatory cytokines and
nitric oxide (NO), and they participate in tissue regeneration through
the production of regulatory cytokines, such as IL10 [39,40]. Propolis
was shown to have an inhibitory effect on inflammatory cytokines, such
as IL12, IL6, GM-CSF, IFN-Ɣ, IL-1β, TNF-α [41–43], and a stimulatory
effect on the regulatory cytokines IL4, IL10, and TGF-β [42,43].
Moreover, it has an inhibitory effect on the chemotaxis of CXCL2/MIP-2
and, hence, could potentially inhibit neutrophil migration [44].
In vivo, the oral administration of propolis enhanced the healing of
the fractured femur in a rat model, as evaluated by radiology, histology,
and bone mineral density [45]. These effects were proposed to be due to
the antioxidant effect of propolis. This was further confirmed by mea-
suring the plasma levels of endogenous antioxidants, superoxide dis-
mutase, myeloperoxidase, and glutathione, which were found to be
significantly decreased after propolis administration [45]. Another
study by Uçan et al. [46] reported that intraperitoneal injection of
CAPE, an active component of propolis, in a rat calvarial defect model
enhanced the efficiency of bone regeneration.
To our knowledge, there are no reports in the literature that de-
scribe the effect of propolis extract on bone marrow-derived mesench-
ymal stromal cells (BMMSCs). Since bone marrow is one of the pre-
ferred sources of mesenchymal stromal cells (MSCs), in this study, we
investigated the effect of propolis extract at different concentrations
towards proliferation, cytotoxicity, and tri-lineage differentiation of
BMMSCs in vitro. In addition, we tested tissue regeneration potential of
propolis in vitro by measuring its effect on the migration capacity of
undifferentiated and differentiated MSCs (osteocyte, chondrocyte, and
adipocyte).
2. Materials and methods
2.1. Bone marrow mesenchymal stromal cells
The isolation and characterization of BMMSCs is as previously de-
scribed [47,48]. Briefly, heparinized bone marrow aspirate from goat
sternum was obtained according to the protocol approved by the In-
stitutional Animal Care and Use Committee, University of Tennessee
(protocol no. 5027). The goats (n=2) were sedated with detomidine
HCl (0.015–0.026mg/kg bwt IV). The skin at the site of harvest was
desensitized by instilling 2% mepivacaine HCl subcutaneously. Ten
milliliters of bone marrow were collected from the region between the
4th-5th sternebra under ultrasound guidance and while administrating
heparin (300 IU/ml). Flunixin meglumine (1.1 mg/kg bwt IV) was in-
jected to provide analgesia after the bone marrow aspiration. The as-
pirate was diluted 1:4 with phosphate buffered saline (PBS), layered
over Ficoll, and centrifuged for 20min at 400 g. The cells containing the
mononuclear fraction at the interface of the PBS and Ficoll were aspi-
rated and washed in PBS by centrifuging for 10min at 200 g. The cell
pellet was then suspended and plated on tissue culture polystyrene
coated flasks in complete growth media composed of Dulbecco’s mod-
ified Eagle medium F-12 (DMEM F12), containing 10% fetal bovine
serum (Hyclone, Logan, UT, USA) and 1% penicillin/streptomycin so-
lution in 37 °C in the presence of 5% CO2 (passage 0). Adherent cells
were harvested by 0.25% trypsin after they reached 80–90% con-
fluency. Cells were re-plated for further expansion or used in the in vitro
assays. BMMSCs between passages 3 to 6 were used in all the experi-
ments described below. All experiments were carried out with 2 in-
dependent cell lines generated from each of the goats and each in vitro
assay was performed in triplicate. This resulted in 2 biological re-
plicates and 3 technical replicates used in this study.
2.2. Preparation of the propolis extract solution
Green propolis extract was commercially obtained (Pharma Nectar,
Brazil). The extract used in this study was obtained from Baccharis
dracunculifolia, a Group 12 Brazilian propolis. Its chemical composition
is as described by the manufacturer (Lot# PC0214.1 V). Based on the
information from the manufacturer, green propolis extract did not
contain any preservatives or artificial ingredients.
The stock solution was prepared by dissolving 8mg of green pro-
polis extract into 40ml Hank’s Balanced Salt Solution (HBSS) and
160 μl of ethyl alcohol. The solution was then kept in a 37 °C water bath
for 30min to ensure the powder was completely dissolved. It was then
filtered using a 0.2 μm syringe filter. This was the stock solution of
100% concentration.
Specific concentrations (10%, 20%, and 40%) of propolis were
prepared from the 100% stock solution in which the propolis stock was
diluted with the complete growth media. The amount of propolis in
each concentration of the working solutions was 200 μg, 400 μg, and
800 μg for 10%, 20%, and 40% concentrations, respectively. Complete
growth media without propolis was used as a control and is referred to
as containing 0% propolis solution.
2.3. Cell proliferation assay
BMMSCs were seeded in 24-well tissue culture polystyrene-coated
plates at a density of 5×103/well in the presence of the complete
growth media containing 0%, 10%, 20%, and 40% propolis. Cell pro-
liferation was measured at 2 time points, days 1 and 3, using CellTitre
96® Aqueous nonradioactive (MTS) assay (Promega, Madison, WI) ac-
cording to the manufacturer’s instructions. Briefly, MTS reagent was
added to the cells and incubated for 3 h at 37 °C in 5% CO2. The ab-
sorbance of the formazan complex that formed was measured at
490 nm. Wells containing the same media without any cells were used
as blank controls.
2.4. Live-dead cell staining
The viability of BMMSCs in the presence of the complete growth
media containing 0%, 10%, 20%, and 40% propolis was visualized
using calcein-am and propidium iodide (PI) staining (green and red
fluorescence, respectively) (Invitrogen). Cells were stained according to
the manufacturer’s instructions after 2 days of seeding. This was carried
out to ensure all cells adhered to the polystyrene tissue culture plates
and were viable. Fluorescent images were acquired using Zeiss Axiovert
40C microscope, equipped with a Canon, Powershot A620 camera, and
images were evaluated with NIS-Elements™ imaging software (Nikon™).
2.5. Nuclear-cytoplasm staining
Nuclear-cytoplasm fluorescent staining was used to evaluate the
morphology of BMMSCs after culturing in the complete growth media
containing 0%, 10%, 20%, and 40% propolis for 7 days. For staining,
cells were fixed with 4% paraformaldehyde for 10min, and next, 5 μg of
wheat germ agglutinin (WGA, Alexa Fluor 488 conjugate) was added
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for 10min at room temperature. After washing, cells were stained with
5 μg of TO-PRO-3 iodide stain (Alexa Fluor 647 conjugate) for 10min at
room temperature. Finally, cells were mounted with SlowFade Gold
Antifade Reagent, and images were taken with a confocal microscope
(Leica TCS SP2; Leica Microsystems©, Wetzlar, Germany) at 20X
magnification.
2.6. Tri-lineage differentiation assays
Osteogenic, chondrogenic, and adipogenic differentiations were
performed as previously described with slight modifications [47,49].
Briefly, 2×105 cells were seeded in the complete growth media con-
taining 0%, 10%, 20%, and 40% propolis. Forty-eight hours later, when
the cells reached 70% confluency, lineage-specific differentiation was
induced. Cells were fed with the lineage-specific differentiation media,
and the concentration of propolis extract was maintained throughout
the differentiation process. For each differentiation assay, an identical
number of cells without any differentiation media were used as con-
trols.
Tri-lineage differentiation was visualized by phase contrast micro-
scopy and cell-specific staining. The following staining techniques were
used: Alizarin red staining at day 21, Alcian blue staining at day 14, and
Oil-red-O staining at day 7, for osteogenesis, chondrogenesis, and adi-
pogenesis, respectively. All images were obtained using a Zeiss Axiovert
40C microscope equipped with a Canon, Powershot A620 camera.
2.7. Migration assay
Migration of undifferentiated BMMSCs in the presence of the com-
plete growth media containing 0%, 10%, and 20% propolis was de-
monstrated in vitro using a scratch assay. BMMSCs were seeded at a
density of 20.000 cells/cm2 to form a monolayer. Migration of differ-
entiated BMMSCs (osteogenic, chondrogenic, and adipogenic differ-
entiated cells) in the presence of the lineage-specific differentiation
media containing 0%, 10%, and 20% propolis was also assessed.
BMMSCs were induced to differentiate using the specific differentiating
media for each type as mentioned above.
In all the undifferentiated and differentiated samples, one scratch/
sample/well was made with a 200 μl pipette tip to ensure that a gap of
400–500 μM was created in each well. Cellular debris was gently wa-
shed with HBSS.
Each scratch assay was repeated in triplicate in two independent
experiments. For gap closure, two randomly selected points along each
“wound” were identified, and the horizontal distance between the two
scratched edges was measured using black and white phase-contrast
microscopy. Measurements were made at day 1, 2, 3, 4, 6, 8, and 10
post-wounding. Measurements taken at each time-point were compared
to measurements at time 0 and then expressed as a percentage healing
relative to the original size of the gap.
2.8. Statistical analysis
All data are reported as mean ± SD. The data was first evaluated
for normality using a Shapiro Wilk test, and after it was confirmed to be
normally distributed, data was compared using a one-way-ANOVA with
Tukey's t-test for post hoc analysis. In all cases, a p-value of p < 0.05
was considered statistically significant.
3. Results
3.1. Propolis enhances cell proliferation and viability
Cell proliferation rate of previously isolated, characterized, and
cryopreserved goat BMMSCs [47] was evaluated in the presence of
green propolis extract in vitro.
Propolis concentrations used in this study were based on a dose
curve, wherein the proliferation of goat BMMSCs was measured in the
presence of 8, 50, 80, and 800 mgs of propolis. Cells exposed to com-
plete growth media without any propolis (referred to as 0%) were used
as controls. Results showed that all the propolis concentrations, except
the 8mg dose, resulted in a significant decrease in cell proliferation
(data not shown). As the 8mg concentration resulted in a significantly
higher proliferation rate in comparison to the 50, 80, and 800 mgs
concentrations, we decided to use 10, 20, 40, 50, and 60% dilutions
from the 8mg stock.
There was a significant increase in cell proliferation in the presence
of 10% propolis only (0.19 ± 0.009) compared to the control
(0.155 ± 0.005) over a period of 3 days (p < 0.05) (Fig. 1). The 20%
and 40% propolis resulted in a significantly higher proliferation rate at
day 1 only (0.151 ± 0.002 and 0.147 ± 0.001, respectively) relative
to the control (0.12 ± 0.002) (p < 0.05). After 3 days, 20% propolis
did not show any significant difference, whereas 40% propolis de-
monstrated a significantly lower proliferation (0.133 ± 0.002). This
was further confirmed by the live/dead fluorescent staining of cells
(Fig. 2). The presence of green fluorescent (calcein-am) and very few
red fluorescent (PI) BMMSCs after 48 h of seeding in the complete
growth media containing 10% and 20% propolis indicated that
BMMSCs were viable and that the 10% and 20% propolis solutions were
not cytotoxic. However, higher concentrations, such as 40% propolis,
were cytotoxic to cells after 2 days of culture, confirming the pro-
liferation assay data at day 3.
Cell morphology was visualized using TO-PRO-3 stain, a probe for
nucleic acid detection, along with WGA specific to the cell membrane,
to demonstrate the nucleus and the cytoplasmic structure of BMMSCs
cultured in complete growth media containing 10%, 20%, and 40%
propolis. Similar to the controls, cells showed an intact nucleus and
healthy cytoplasm using fluorescence microscopy. No differences were
observed between the four groups, except lower numbers of cells were
observed in 40% propolis (Fig. 3), confirming the reduced proliferation
and cytotoxicity.
3.2. Propolis enhances chondrogenic and adipogenic differentiation, but not
osteogenic differentiation
To determine the multipotency of the BMMSCs in the presence of
propolis in vitro, cells were induced to differentiate to osteogenic,
chondrogenic, and adipogenic lineages in the presence of 10%, 20%,
and 40% propolis. In this assay, lineage-specific media without propolis
was used as the 0% differentiation media control for each cell type.
Subjective evaluation by Alizarin red staining showed that BMMSCs
treated with all three concentrations of propolis did not show any
Fig. 1. Proliferation of BMMSCs. MTS assay was used to demonstrate the pro-
liferation of BMMSCs cultured in complete growth media containing 0%, 10%,
20%, and 40% propolis over a period of 3 days. *P < 0.05 is considered sig-
nificant. The dotted line represents the control value and bars above or below
demonstrate changes relative to the control.
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mineralized nodules compared to the control (Fig. 4A), suggesting that
cells failed to undergo osteogenic differentiation in the presence of
propolis. However, as judged by Alcian blue staining, BMMSCs de-
monstrated the potential to undergo chondrogenesis in vitro when
grown in the lineage-specific medium in the presence of 10% and 20%
(Fig. 4B). Similarly, as confirmed by Oil red O staining (Fig. 4C), 10%
propolis treated cells showed a higher formation of fat droplets com-
pared to the control. On the contrary, 20% and 40% propolis showed
relatively less accumulation of fat droplets relative to the control.
3.3. Propolis enhances migration of BMMSCs and promotes gap closure in
vitro
An in vitro scratch assay was performed to mimic the in vivo effect of
propolis on wound healing. Using this test, the undifferentiated BMMSC
migration and wound gap closure was assessed in the presence of
complete growth media containing 0%, 10%, and 20% propolis over a
period of 10 days. Almost 85% of gap closure was observed at day 4 in
all groups tested. Data was not significant at any time point (Fig. 5).
Since the 40% propolis solution demonstrated a lower proliferation rate
and some cell death (Figs. 1,2), it was not used in the migration assay.
The migration capacity of BMMSCs induced for osteogenic, cho-
drogenic, and adipogenic lineages was also assessed in the presence of
differentiation media containing 0%, 10%, and 20% propolis. The gap
closure of cells after osteogenic differentiation in presence of propolis
was significantly shorter than the control until day 6 for 20% but re-
lapsed after day 8 and became significantly longer than the control
thereafter (Fig. 6A). Alizarin red staining of the cells after migration
showed poor osteogenic differentiation in both 10% and 20% propolis-
treated cells compared to the control (Fig. 6B), again confirming the
earlier data that propolis extract inhibits osteogenesis (Fig. 4). On the
other hand, 10% propolis upregulated chondrogenic lineage differ-
entiation at 24 h, and this effect sustained until the end of the experi-
ment at day 10. Both 10% and 20% propolis-treated cells showed sig-
nificantly higher migration capacity at days 3, 6, and 10 (Fig. 7A).
Alcian blue staining of the cells revealed an efficient migration of
chondrocytes to close the gap in the presence of 10% and 20% propolis
relative to the control (Fig. 7B). Similarly, significant effects in gap
closure were consistently observed at days 1, 2, 3, and 4 in adipogenic
cells with 20% propolis (Fig. 8A). At days 6, 8, and 10, both 10% and
20% propolis-treated adipocytes exhibited significantly higher migra-
tion capacity relative to the control (p < 0.05). Staining the adipocyte-
induced cells using Oil red-O revealed significantly higher fat droplets
in the presence of 20% propolis relative to the control (Fig. 8B).
4. Discussion
Green propolis extract used in this study was commercially obtained
(Pharma Nectar, Brazil), and active components reported were
Coumaric acid, Pinobankisin, pnocembrin, Pinobanksin-3-acetate,
chrysin, Galahgin, Artepillin C, and Baccharin. Propolis belongs to
group 12 of Brazilian propolis, and its botanical origin is identified as
Baccharis dracunculifolia.
Many studies have tested the effect of propolis on not only grafts
and tissues, but also on different cell lines in vitro; however, there are no
reports on its effect on bone marrow-derived MSCs. Herein, we used in
vitro experiments to evaluate the cytotoxic effect of propolis quantita-
tively and qualitatively. Our results revealed that propolis was not cy-
totoxic at concentrations lower than 400 μg/ml to BMMSCs, and in fact,
it increased the proliferation rate of BMMSCs. This finding was in
agreement with previously published studies, which reported that
propolis could enhance the proliferation capacity of periodontal liga-
ment fibroblast [38] and stem cells derived from exfoliated deciduous
teeth [28]. However, an opposite effect was reported by Tyszka-Czo-
chara et al., who observed that propolis exhibited an anti-proliferative
effect on skin fibroblast [32].
Propolis is one of the natural extracts used for osteoarthritis due to
its anti-inflammatory effect, which has been shown in an in vivo ar-
thritis-induced animal model [50–53]. In the present study, as con-
firmed by Alcian blue staining for the glycosaminoglycans (GAG),
propolis showed aggregated GAG at 10% and 20% concentrations. This
effect was also observed at 50% concentration (data not shown). It has
recently been shown that propolis extract could increase the extra-
cellular matrix GAG and hyaluronic acid in a minor skin burn [54]. In
Fig. 2. Cell viability of BMMSCs. Fluorescent staining was carried out 48 h after seeding BMMSCs in complete growth media containing 0%, 10%, 20%, and 40%
propolis. Cells were stained with Calcein-am, which emits green fluorescence in live cells. Lack/reduced red fluorescently stained cells by PI indicates dead cells.
Scale bar= 100 μm; images were taken at 10x magnification.
Fig. 3. Nuclear-cytoplasmic morphology of BMMSCs. Representative confocal images of cytoplasmic (WGA, green) and nuclear (TOPRO-3-iodide, red) fluorescent
stains show the integrity of BMMSCs cultured in complete growth media containing 0%, 10%, 20%, and 40% propolis. Cells were stained after 7 days of seeding and
proliferation. Scale bar= 25 μm.
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another study, propolis has been reported to increase collagen pro-
duction in an animal model of diabetic wound healing via TGF-β1/
Smad2 signaling [55]. The published studies and data reported in this
study suggest that the dose of propolis used is important, and propolis
extract at a defined concentration can be used as a suitable medium for
the storage and transportation of osteochondral graft and as a multi-
functional carrier for stem cell therapy in osteoarthritis patients.
We observed that BMMSCs showed poor osteogenic differentiation
in the presence of propolis, suggesting that propolis extract may exert
an inhibitory effect on osteogenic differentiation. This result is sup-
ported by Hidaka et al. [56] in which they demonstrated that propolis
exerted an inhibitory effect on amorphous calcium phosphate forma-
tion. However, studies by Guney et al. [45] and Altan et al. [57] pro-
posed a potential role for propolis in bone regeneration. It seems that
this in vivo effect could be due to either its inhibitory effect on the os-
teoclast maturation as explained by Pileggi et al. [30] or due to change
in the antioxidant levels at the site of the fracture as investigated by
Guney et al. [45]. Our data suggest the bone regenerative effect of oral
propolis may not be via induction of osteodifferentiation of MSCs as
believed by some researchers. Future experiments to understand the
lack of osteogenic differentiation observed in our study need to be in-
itiated.
Some studies suggest that the injection of differentiated cells will
promote tissue regeneration [58–61]. As per our knowledge, there are
no reports about the capacity of differentiated cells to migrate to the
site of injury. Herein, we evaluated the effect of propolis on the in vitro
migration potential of both undifferentiated and differentiated MSCs
using scratch assay. Data shows that 10% and 20% propolis can po-
tentiate the migration capacity of both chondro- and adipo-differ-
entiated MSCs. The effect of propolis on migration potential of differ-
entiated cells observed in this study is novel and has not been reported
earlier. Previously, a single report by Jacob et al. [33] shows that
Fig. 4. Tri-lineage differentiation i.e. osteogenic, chondrogenic, and adipogenic differentiation of BMMSCs. Representative images show Alizarin red (A), Alcian blue
(B), and Oil red O (C) staining of osteocytes, chondrocytes, and adipocytes, respectively, after in vitro differentiation in lineage-specific differentiation media
containing 0%, 10%, 20%, and 40% propolis.
Fig. 5. Migration assay of undifferentiated (non-differentiated)
BMMSCs. Quantitative analysis of the migration distance of
BMMSCs cultured in complete growth media containing 0%, 10%,
and 20% propolis. Results are shown as the mean ± SD of tripli-
cates within two independent experiments. None of the data is
significant.
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1000 μg/ml propolis has an enhancing effect on skin fibroblast migra-
tion in vitro.
In terms of clinical applications, future studies would determine
whether propolis increases the viability and physiological health of
osteochondral graft and can act as a storage media, as it did for the
avulsed tooth. In addition, a cartilage defect animal model can be used
to determine the effect of propolis as a carrier for MSCs to enhance
cartilage regeneration.
5. Conclusions
Within the scope of this study, we have demonstrated that propolis
at concentrations of ≤ 400 μg/ml was not cytotoxic to BMMSCs and
enhanced their proliferation. The higher concentrations, however,
hindered the proliferation and exhibited a cytotoxic effect. Most im-
portantly, we demonstrated that propolis enhanced the chondrogenic
and adipogenic differentiation processes and increased the migration
potential of differentiated cells from both lineages. In line with the
previous reports, our data supports the fact that propolis at a defined
concentration is safe, cytocompatible, and, hence, can be used as an
adjuvant therapeutic supplement which has the potential to enhance
the proliferation and the tissue regeneration potential of MSCs. Due to
the high degree of variability in the chemical composition of propolis
extracts obtained from different geographical locations, these in vitro
analyses should be performed prior to in vivo application. Most im-
portantly, the in vitro system reported in this study provides an avenue
to understand the mechanisms of osteogenic, chondrogenic, and adi-
pogenic differentiation processes of MSCs in the presence of a defined
dose and type of propolis extract.
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Fig. 6. Migration assay during osteogenic dif-
ferentiation of BMMSCs. (A) Quantitative ana-
lysis to compare the migration of BMMSCs
cultured in osteogenic differentiation media
containing 0%, 10%, and 20% propolis. Results
are shown as the mean ± SD of triplicates
within two independent experiments.
*P < 0.05 is considered significant. (B)
Representative images showing the corre-
sponding Alizarin red staining for osteogenic
differentiation.
Fig. 7. Migration assay during chondrogenic
differentiation of BMMSCs. (A) Quantitative
analysis to compare the migration of BMMSCs
cultured in chondrogenic differentiation media
containing 0%, 10%, and 20% propolis. Results
are shown as the mean ± SD of triplicates
within two independent experiments.
*P < 0.05 is considered significant. (B)
Representative images showing the corre-
sponding Alcian Blue staining for chondrogenic
differentiation.
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